Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02310230 · ClinicalTrials.gov registry record · NA
An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy
A NA study of Barrett Esophagus and Stomach Neoplasms, sponsored by Donald Mathews.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02310230 is a NA study of Barrett Esophagus and Stomach Neoplasms that has completed, run by Donald Mathews. The registered enrollment target is 100 participants, below the 3,562-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02310230, a NA study of Barrett Esophagus and Stomach Neoplasms, has completed, sponsored by Donald Mathews.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose: To assess the utility of a new medical device that monitors a patient's breathing during medical procedures in which a patient is sedated, but not mechanically ventilated. In minor procedures, such as endoscopy (where the doctor examines a patient's digestive tract by a TV camera inserted through the mouth), patients do not require general anesthesia, in which a machine would take over their breathing while they are unconscious for surgery. However, during endoscopic procedures it is sometimes difficult for the anesthesiologist to monitor the patient's breathing-specifically, to monitor changes in breathing patterns and the adequacy of breathing. In endoscopy procedures, the room is darkened, and the patient's mouth is generally occupied by the endoscope. While the anesthesiologist can listen to the patient's breathing sounds with a stethoscope, this type of monitoring can only be done periodically, and there is limited ability to gauge the adequacy of ventilation. This study will use the ExSpiron Respiratory Volume Monitor (RVM), which measures non-invasive minute ventilation (MV), tidal volume (TV) and respiratory rate (RR), in patients undergoing an endoscopic procedure to provide additional information regarding the effects of clinical interventions such as drug administrations or airway maneuvers on the patient's respiratory status. For patients who give informed consent, study participation means that they will have a PadSet consisting of 3 electrodes applied to the chest. Another component, a nasal cannula (a thin clear plastic tube that goes under the nose) will give patients supplemental oxygen, and is standard of care for endoscopy at UVM Medical Center. Patients will then be asked to breathe in and out of a portable spirometer (breath meter) for 30 seconds up to five times. This data will be compared to data recorded by the monitor to confirm that the monitor is recording accurately. The procedure will then go forward in the normal fashion. Pati
Conditions Studied
Interventions
- DEVICE ExSpiron Respiratory Variation Monitor
Study Locations (1)
Vermont
- University of Vermont Medical Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-09-22 |
| Est. Completion | 2016-05-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02310230
The ClinicalTrials.gov registry entry for NCT02310230 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,562-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (97% lower). The listed sponsor is Donald Mathews, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which ExSpiron Respiratory Variation Monitor is the first listed.
NCT02310230 reports 1 study location spanning 1 distinct geographic area - top geographies include Vermont.
Frequently Asked Questions
What is clinical trial NCT02310230 about?
NCT02310230 is a clinical study titled "An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy". Purpose: To assess the utility of a new medical device that monitors a patient's breathing during medical procedures in which a patient is sedated, but not mechanically ventilated. In minor procedures, such as endoscopy (where the doctor examines a patient's digestive tract by a TV camera inserted t...
What is the current status of trial NCT02310230?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2014-09-22. Estimated completion is 2016-05-09.
What conditions does trial NCT02310230 study?
This clinical trial studies the following conditions: Barrett Esophagus, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Biliary Tract Diseases.
What interventions are being tested in trial NCT02310230?
The interventions under investigation include: ExSpiron Respiratory Variation Monitor (DEVICE).
Who is sponsoring clinical trial NCT02310230?
This trial is sponsored by Donald Mathews, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02310230 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
RECRUITING · NA
-
Pilot Study for OCT Guided In Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's Esophagus
RECRUITING · NA
-
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.